Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $3.23 Million - $3.63 Million
-23,443 Reduced 86.3%
3,723 $577,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $3.63 Million - $4.2 Million
27,166 New
27,166 $4.05 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $3.84 Million - $4.42 Million
-26,564 Reduced 31.69%
57,266 $9.13 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $795,559 - $954,084
-5,752 Reduced 6.42%
83,830 $13.5 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $5.23 Million - $5.99 Million
38,935 Added 76.88%
89,582 $12 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $1.93 Million - $2.45 Million
13,993 Added 38.18%
50,647 $7.76 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $754,793 - $936,486
5,719 Added 18.49%
36,654 $5.94 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $13,965 - $17,670
-130 Reduced 0.42%
30,935 $4.19 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $537,852 - $610,542
5,055 Added 19.43%
31,065 $3.35 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $427,363 - $476,107
-4,062 Reduced 13.51%
26,010 $2.93 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $59,436 - $65,432
-581 Reduced 1.9%
30,072 $3.25 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $2.47 Million - $3.33 Million
30,653 New
30,653 $3.28 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $452,745 - $531,374
-5,270 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $386,659 - $517,408
5,270 New
5,270 $517,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $836,203 - $1.05 Million
-11,593 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $844,372 - $1.02 Million
-13,407 Reduced 53.63%
11,593 $878,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $1.31 Million - $1.68 Million
20,000 Added 400.0%
25,000 $1.82 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $385,700 - $453,950
5,000 New
5,000 $403,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.